Stratification of the Low-Latitude and Near-Equatorial F2 Layer, Topside Ionization Ledge, and F3 Layer: What We Know about This? A Review

Por M. V. Klimenko, B. Zhao, A. T. Karpachev, V. V. Klimenko
Publicado em 2012-01-01

Changes in sonoelastography indices of stiffness as a criterion of evaluation of efficiency of neoadjuvant chemotherapy for breast cancer

Por E. A. Bus'ko, T. Yu. Semiglazooa, V. V. Klimenko, A. V. Komiyakhoo, A. V. Mshchenko, V. V. Serniiglazoo
Publicado em 2014-03-01

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment

Por V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov
Publicado em 2018-07-01

PERORAL FORMS OF CYTOSTATIC DRUGS IN THERAPY OF METASTATIC MAMMARY GLAND CANCER: ROLE IN CLINICAL PRACTICE

Por G. M. TELETAEVA, T. Y. SEMIGLAZOVA, А. S. ZHABINA, D. H. LATIPOVA, V. V. KLIMENKO, Z. S. KOTOVA, A. I. SEMENOVA, S. A. PROTSENKO, V. V. SEMIGLAZOV
Publicado em 2016-12-01

Analysis results of surgical treatment and chemoradiotherapy with assessment of prognostic factors in localy advanced laryngeal cancer

Por Z. A.‑G. Radzhabova, M. A. Kotov, M. M. Girshovich, O. I. Ponomareva, E. V. Kostromina, M. A. Radzhabova, A. S. Mitrofanov, V. V. Klimenko, E. V. Levchenko
Publicado em 2022-02-01

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases

Por T.  Yu.  Semiglazova, S.  M.  Sharashenidze, S.  N.  Kerimova, V.   V. Klimenko, A. Yu.  Malygin, G.  A.  Dashyan, R.   M. Paltuev, V.  V.  Semiglazov, P.   V. Krivorotko, S.  N.  Novikov, V.   F. Semiglazov
Publicado em 2021-06-01

EVALUATION OF MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHANGES OF BREAST CARCINOMAS AFTER NEOADJUVANT SYSTEMIC THERAPY

Por V. О. Bashlyk, V. F. Semiglazov, A. G. Kudaybergenova, A. S. Artem’eva, T. Yu. Semiglazova, V. S. Chirskiy, A. V. Komyakho, P. V. Krivorot’ko, V. V. Klimenko, Sh. M. Khadzhimatova, A. I. Tseluyko, S. S. Ereschenko
Publicado em 2018-04-01

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER

Por V. F. Semiglazov, V. V. Semiglazov, G. A. Dashyan, P. V. Krivorotko, V. G. Ivanov, E. K. Zhiltsova, R. M. Paltuev, L. M. Bershtein, T. Yu. Semiglazova, S. S. Yerechshenko, V. V. Klimenko, V. S. Apollonova, A. V. Komyahov, A. A. Bessonov
Publicado em 2018-07-01

Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome

Por F.V. Moiseenko, N.M. Volkov, A.S. Zhabina, M.L. Stepanova, N.A. Rysev, V.V. Klimenko, A.V. Myslik, E.V. Artemieva, V.V. Egorenkov, N.H. Abduloeva, A.O. Ivantsov, E.S. Kuligina, E.N. Imyanitov, V.M. Moiseyenko
Publicado em 2022-01-01

NEW ADVANCES IN THE TREATMENT OF BREAST CANCER: THE ROLE EPOTHILONES

Por T. Y. SEMIGLAZOVA, V. A. KLYUGE, E. A. KOROBEYNIKOVA, P. V. KRIVOROTKO, R. M. PALTUEV, G. M. TELETAEVA, D. H. LATIPOVA, V. V. KLIMENKO, E. V. TACHENKO, A. V. Novik, A. I. SEMENOVA, V. V. SEMIGLAZOV, S. A. PROTSENKO, V. F. SEMIGLAZOV
Publicado em 2017-06-01

Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer

Por T. Yu. Semiglazova, E. V. Lubennikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, A. V. Avramenko, E. V. Artemeva, S. A. Borozdina, A. A. Vakhitova, N. M. Volkov, I. P. Ganshina, Sh. A. Dzhalilova, L. G. Zhukova, B. S. Kasparov, A. A. Kachmazov, V. V. Klimenko, A. i. Kornietskaya, A. A. Meshcheryakov, A. A. Paichadze, A. N. Poltoratsky, O. E. Ryabishina, M. L. Stepanova, E. N Imyanitov
Publicado em 2020-12-01